Registration

PARRY, ROMANI, DECONCINI & SYMMS for BRAIDWOOD MANAGEMENT, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. Support of H. Con. Res. 342 and S. Con. Res. 88, Expressing the sense of Congress that the Food and Drug Admin.'s new policy restricting women's access to medications containing estriol does not serve the public interest (intro. in House & Senate).

LobbyistCovered position, as disclosed
DENNIS DECONCINI New U.S. Senator, 1977 to 1995
JAMES ROCK New —
ROMANO ROMANI New —
THADDEUS E STROM New Gen Counsel/Staff Dir, Sen Cmte on the Judiciary - 1988-1991Chief Counsel/Staff Dir, Sen Cmte on the Judiciary-1991-1993Chief Counsel/Staff Dir, Sen Subcommittee on Antitrust,Business Rights and Competition - 1994 - 1997
STEVE SYMMS New —

Bills named: H.Con.Res. 342 (110th), S.Con.Res. 88 (110th)

Pharmacy PHA

Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. Support of H. Con. Res. 342 and S. Con. Res. 88, Expressing the sense of Congress that the Food and Drug Admin.'s new policy restricting women's access to medications containing estriol does not serve the public interest (intro. in House & Senate).

LobbyistCovered position, as disclosed
DENNIS DECONCINI New U.S. Senator, 1977 to 1995
JAMES ROCK New —
ROMANO ROMANI New —
THADDEUS E STROM New Gen Counsel/Staff Dir, Sen Cmte on the Judiciary - 1988-1991Chief Counsel/Staff Dir, Sen Cmte on the Judiciary-1991-1993Chief Counsel/Staff Dir, Sen Subcommittee on Antitrust,Business Rights and Competition - 1994 - 1997
STEVE SYMMS New —

Bills named: H.Con.Res. 342 (110th), S.Con.Res. 88 (110th)

Medical/Disease Research/Clinical Labs MED

Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. Support of H. Con. Res. 342 and S. Con. Res. 88, Expressing the sense of Congress that the Food and Drug Admin.'s new policy restricting women's access to medications containing estriol does not serve the public interest (intro. in House & Senate).

LobbyistCovered position, as disclosed
DENNIS DECONCINI New U.S. Senator, 1977 to 1995
JAMES ROCK New —
ROMANO ROMANI New —
THADDEUS E STROM New Gen Counsel/Staff Dir, Sen Cmte on the Judiciary - 1988-1991Chief Counsel/Staff Dir, Sen Cmte on the Judiciary-1991-1993Chief Counsel/Staff Dir, Sen Subcommittee on Antitrust,Business Rights and Competition - 1994 - 1997
STEVE SYMMS New —

Bills named: H.Con.Res. 342 (110th), S.Con.Res. 88 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.